PET (positron emission tomography)/CT (computed tomography) may find vulnerable aortic plaque:
This article was originally published in Clinica
Combined PET and CT scans may be able to predict severe cadiovascular events by revealing early pathological changes in the aortic wall and blood vessels. A certain percentage of the sites that uptake the radiopharmaceutical FDG (fluorodeoxyglucose) potentially correspond to high risk or vulnerable atherosclerotic lesions that could lead to future cardiovascular events, said lead researcher Mitsuaki Tatsumi, of the Johns Hopkins University School of Medicine. He added that follow-up clinical and pathological studies are needed to prove the hypothesis. The findings were revealed at this month's Society of Nuclear Medicine's annual meeting in Los Angeles, California.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.